SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
SERA

Sera Prognostics, Inc. (NASDAQ:SERA)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$1.81-$0.08 (-4.23%)
 
Market cap
$70.2M
Insider Score
Health Score
Analyst consensus
Listed since
Jul 15, 2021
Website
Market Cap$70.23M-46.5%
Revenue (ttm)$96.00K+1.1%
Net Income-$33.47M-2.6%
EPS-$0.67+13.0%
Shares Out38.80M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume94,600
Open$1.85
Previous Close$1.89
Day's Range$1.80 - $1.85
52-Week Range$1.56 - $3.85
Beta1.14
AnalystsBuy
Price Target$6.00(+231.49%)
Earnings DateMar 17, 2027
-4.23% (1D)
No price history available.

About SERA

Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally, the company is cultivating a portfolio of potential tests for various other pregnancy-related conditions, such as preeclampsia, predicting time-to-birth at a molecular level, gestational diabetes mellitus, restricted fetal growth, stillbirth, and postpartum depression. Established in 2008, the organization's main operations are based in Salt Lake City, Utah.

Address
2749 East Parleys Way, Salt Lake City, UT, 84109, US
Market Cap
70 million
Employees
72
Industrial Classification
Medical - Devices

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$123.65K
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Weak
From SERA’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-4.23%
5 Days
-9.50%
1 Month
-11.27%
6 Months
-12.56%
1 Year
-46.45%

$SERA stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in SERA holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by SERA's directors and management

Net Shares Purchased by Insiders−40k−20k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

SERA Estimated quarterly lobbying spending

Source: U.S. Senate LDA

SERA Revenue by Segment

$2.44MTotal
Consulting and professional fees$1.45M59.45%
Other income, net$836.00K34.28%
Clinical studies and outside processing$111.00K4.55%
Single Reporting Segment$42.00K1.72%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New SERA patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to SERA from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in SERA

VTIVanguard Morningstar Total Stock Market ETF$1.43M
VXFVanguard Extended Market ETF$775.63K
IWCiShares Micro-Cap ETF$178.47K
BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF$90.00K
AVSCAvantis U.S. Small Cap Equity ETF$10.21K
DCORU.S. Core Equity 1 Portfolio ETF Class Shares$9.64K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from SERA’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
0
Analyst Ratings
40% of score
60
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
12
Buy Value
$0
Distinct Buyers
0

Insider Score Trend Over Time

+0.0 since Sep 10
0255075100Sep 10 — Insider Score 0.0Sep 11 — Insider Score 0.0Sep 12 — Insider Score 0.0Sep 13 — Insider Score 0.0Sep 14 — Insider Score 0.0Sep 15 — Insider Score 0.0Sep 16 — Insider Score 0.0Sep 17 — Insider Score 0.0Sep 18 — Insider Score 0.0Sep 19 — Insider Score 0.0Sep 20 — Insider Score 0.0Sep 21 — Insider Score 0.0Sep 22 — Insider Score 0.0Sep 23 — Insider Score 0.0Sep 24 — Insider Score 0.0Sep 25 — Insider Score 0.0Sep 26 — Insider Score 0.0Sep 27 — Insider Score 0.0Sep 28 — Insider Score 0.0Sep 29 — Insider Score 0.0Sep 30 — Insider Score 0.0Oct 1 — Insider Score 0.0Oct 2 — Insider Score 39.0Oct 3 — Insider Score 0.0Oct 4 — Insider Score 0.0Sep 10Sep 22Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF0.09%

Weight is the stock’s share of each fund’s holdings.